Truvestments Capital’s Transmedics TMDX Stock Holding History

Truvestments Capital’s Portfolio TMDX Stock Details TMDX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$5.67K	Hold	57	–	–	﹤0.01%	862
2025 Q4	$6.93K	Hold	57	–	–	﹤0.01%	749
2025 Q3	$6.39K	Hold	57	–	–	﹤0.01%	775
2025 Q2	$7.64K	Hold	57	–	–	﹤0.01%	684
2025 Q1	$3.83K	Hold	57	–	–	﹤0.01%	782
2024 Q4	$3.55K	Hold	57	–	–	﹤0.01%	748
2024 Q3	$8.95K	Buy	+57	New	+$8.78K	﹤0.01%	598
2024 Q2	–	Sell	-90	Closed	-$6.66K	–	646
2024 Q1	$6.66K	Hold	90	–	–	﹤0.01%	527
2023 Q4	$7.1K	Hold	90	–	–	﹤0.01%	548
2023 Q3	$4.93K	Hold	90	–	–	﹤0.01%	515
2023 Q2	$7.56K	Hold	90	–	–	﹤0.01%	479
2023 Q1	$6.82K	Buy	+90	New	+$6.22K	﹤0.01%	473

Other funds holding TMDX

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

VPM

Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

UBS AM Chicago, Illinois $481B AUM 26.39% 1-Year Est. Return

NAMI

Nomura Asset Management International Philadelphia, Pennsylvania $58.4B AUM

Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Truvestments Capital's TMDX Position: Q1 2026 in Review

Truvestments Capital held its Transmedics (TMDX) position steady in Q1 2026 at 57 shares worth $5.67K. The position accounts for ﹤0.01% of the portfolio, ranked #862.

Truvestments Capital first reported a position in TMDX in Q1 2023 and has held it in 12 quarters since. The position peaked at $8.95K in Q3 2024. 414 funds tracked by Wall St. Rank hold TMDX as of Q1 2026.

Truvestments Capital held 57 shares of Transmedics worth $5.67K as of Q1 2026.
Truvestments Capital left its Transmedics share count unchanged in Q1 2026.
Transmedics made up ﹤0.01% of Truvestments Capital's portfolio in Q1 2026, its #862 holding.
Truvestments Capital first reported a position in Transmedics in Q1 2023 and has held it in 12 quarters since.
Truvestments Capital's Transmedics position peaked at $8.95K in Q3 2024.
414 funds tracked by Wall St. Rank held Transmedics as of Q1 2026.

Based on Truvestments Capital's 13F filing for Q1 2026, filed 13 May 2026.